Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes
What is the purpose of this trial?
The purpose of this study is to assess how glucagon administered as a puff into the nose (AMG504-1) works in children and adolescents compared with commercially-available glucagon given by injection. In addition, the safety and tolerability of glucagon given as a puff into the nose will be evaluated.
- 4 Years - 16 Years
- Jaeb Center for Health Research
- Last Updated:
- Study HIC#: